Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Avricore Health Inc (AVCRF) operate in?
Avricore Health Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Avricore Health Inc (AVCRF) current stock price?
As of the latest data, Avricore Health Inc stock price is $0.00, with a previous close of $0.00.
What is Avricore Health Inc (AVCRF) current market capitalization?
Avricore Health Inc market cap is approximately 101.10 thousand.
What is Avricore Health Inc (AVCRF) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
What is Avricore Health Inc (AVCRF) EBITDA?
Avricore Health Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -156.35 thousand.
Does Avricore Health Inc (AVCRF) pay dividends?
No. Avricore Health Inc does not pay a dividend.
What is Avricore Health Inc (AVCRF) beta (volatility) score?
Avricore Health Inc has a beta of 0.396, indicating lower volatility than the overall market.